Mariella Ferrari
Milan, 20156, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Validated LC-MS/MS Assay for the Quantitative Determination of Fenretinide in Plasma and Tumor and Its Application in a Pharmacokinetic Study in Mice of a Novel Oral Nanoformulation of Fenretinide.
Journal: Pharmaceutics
Published: February 16, 2024
A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 02, 2019
Readily prepared biodegradable nanoparticles to formulate poorly water soluble drugs improving their pharmacological properties: The example of trabectedin.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 14, 2017
Prompt detection of L-asparaginase inactivation is crucial to optimize treatment efficacy also in aggressive lymphomas.
Journal: Hematological oncology
Published: September 17, 2017
Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations.
Journal: Cancer chemotherapy and pharmacology
Published: February 14, 2017
Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy.
Journal: Neurobiology of disease
Published: October 27, 2016
In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer Models.
Journal: Neoplasia (New York, N.Y.)
Published: October 19, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026